Drug hearings
This article was originally published in The Tan Sheet
Executive Summary
House Energy & Commerce Committee aims to act on several drug-related issues this fall, likely beginning with markup of drug reimportation bill in late September. Committee is writing bill currently and working with FDA on safety language. Senate drug reimportation language passed as part of generic drug bill (S 812) includes a provision requiring HHS certification. Commerce also is looking at third week of September for hearing on Hatch/Waxman issues, although date could slip back into October. Time will likely be an issue, however, as Congress is targeting Oct. 4 for adjournment...